Net Profit/3 604.5 340.6 (263.8) (43.6%) /1 Including other income and share of profit from investments in associates and JVs /2 Gross profit including share of profit from investments in associates and

- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager

ter 2 Quar ter 1-2 Profit Attributable to Owner of the Parent - Previously Reported 2,200.99 3,559.43 Finance Costs (Increase) / Decrease (114.61) (297.48) Share of Profit of Associates and Joint

attributable to owners of the Company 2,412 2,084 993 -59% -52% 2,681 3,076 15% Basic earnings per share (Baht) 1.75 1.51 0.72 1.95 2.23 Note: 1/ EBITDA from Refinery Business of the Company, BCP Trading Pte

the products. Furthermore, the selling points in departments and modern trade will be expanded to cover the area Besides, the Company also has the policy to add more the assets and expand the channels

(Translation) — 1 — (Translation) No. 10000000/ 152 /61 20 June 2018 Subject: Resolutions passed by the Board of Directors Meeting regarding the share acquisition, the tender offer for the entire

) % December , December , Assets . . . . % Liabilities . . . . % Shareholders' equity . . . . % Issued and fully paid-up common share (Million Share) . . . . % Par (Baht) . . . . % 4.1 Assets Overall asset as at

were back on track with 44.5% growth YoY and 3.4% growth QoQ. - In Q1’19, the Company maintained its leadership position with total market share of 31.1% in Brain and Body Boost (“BBB”) products which

executionn !&% %,"O*)()* route trade 6 +".%()* criteria )#$\! .'+!C#[/+P*M$ \% " ' (#"O*! ̀* !!"'% #()* business structure ')'#+"'$".'O,"f+ "%"$(#S#$+]bML")'#+"O.'* L P. trading venues

. Share of profit (loss) from investment in associated company For Quarter 2 of the year 2020, share of profit from investment in associated company was 9.19 million baht compare to 4.92 million bath last